- Home
- ACA vs TERN Comparison
ACA vs TERN Comparison
Compare ACA & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACA | TERN |
|---|---|---|
| Founded | 2018 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.8B |
| IPO Year | 2018 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ACA | TERN |
|---|---|---|
| Price | $111.26 | $52.73 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 12 |
| Target Price | ★ $120.00 | $46.49 |
| AVG Volume (30 Days) | 237.0K | ★ 10.4M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.17% | N/A |
| EPS Growth | ★ 121.99 | 8.04 |
| EPS | ★ 4.24 | N/A |
| Revenue | ★ $2,883,400,000.00 | N/A |
| Revenue This Year | $4.98 | N/A |
| Revenue Next Year | $6.67 | N/A |
| P/E Ratio | $26.93 | ★ N/A |
| Revenue Growth | ★ 12.20 | N/A |
| 52 Week Low | $73.93 | $2.23 |
| 52 Week High | $131.00 | $53.19 |
Technical Indicators
Market Signals| Indicator | ACA | TERN |
|---|---|---|
| Relative Strength Index (RSI) | 53.22 | 73.86 |
| Support Level | $106.48 | $52.42 |
| Resistance Level | $113.08 | $53.19 |
| Average True Range (ATR) | 3.33 | 0.16 |
| MACD | 1.24 | -0.39 |
| Stochastic Oscillator | 74.35 | 37.01 |
Price Performance
Historical ComparisonAbout ACA Arcosa Inc.
Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.